NTR Posts Strong Q4 Results: Revenue Beats Expectations While Earnings Miss Slightly

Nutrien Ltd. (NTR) delivered a solid quarterly performance for the fourth quarter of 2025, reporting total revenue of $5.34 billion, which exceeded Wall Street’s consensus estimate of $5.21 billion by 2.55%. However, the company’s earnings per share of $0.83 fell slightly short of the $0.87 consensus projection, marking a -4.96% variance. Despite the modest EPS shortfall, the revenue outperformance and underlying operational metrics reveal important insights into NTR’s business trajectory that often matter more to long-term investors than headline numbers alone.

Key Operating Metrics Drive the Narrative

When analyzing NTR’s quarterly performance, investors typically focus on how sales volumes and pricing power align with analyst expectations—metrics that directly influence both revenue and profitability. The company’s performance across its core product segments tells a nuanced story.

In the potash division, NTR achieved sales volumes of 2,803 KTon, trailing the three-analyst average estimate of 2,876.83 KTon. The nitrogen segment reported 2,575 KTon in sales volumes versus the projected 2,667.94 KTon based on analyst consensus. While both segments underperformed volume expectations, NTR demonstrated remarkable pricing strength across its phosphate operations. The average selling price for industrial and feed phosphate reached $875 per ton—a substantial 22.6% premium to the $713.89 analyst consensus. Total phosphate pricing averaged $733 per ton, far outpacing the estimated $574.04 consensus estimate.

Revenue Performance Across Business Segments

Breaking down NTR’s performance by operational segment reveals mixed but encouraging trends. The Retail segment (Nutrient Ag Solutions) generated $3.14 billion in sales, slightly missing the five-analyst average estimate of $3.21 billion, though this represents only a 1.1% variance. This modest decline reflects challenges in retail distribution but masks stronger underlying performance in the company’s core commodity divisions.

The potash business generated $792 million in segment sales versus $804.4 million estimated, yet achieved an impressive 34.9% year-over-year increase. NTR’s nitrogen segment posted $1.24 billion in sales, outperforming the $1.09 billion consensus estimate and gaining 5.4% compared to the prior-year quarter. The phosphate business delivered $543 million, surpassing $513.52 million consensus projection with a robust 15.3% year-over-year advance.

On a net sales basis—accounting for intersegment eliminations—NTR’s performance proved even more compelling. Net nitrogen sales reached $1.09 billion against a $990.83 million consensus estimate, reflecting 7.9% year-over-year growth. Net potash sales of $736 million significantly outpaced $706.92 million consensus estimate, posting 37.3% year-over-year gains. Net phosphate sales totaled $483 million, beating the $421.42 million consensus projection with 16.7% year-over-year growth.

Market Reception and Forward Outlook

NTR shares appreciated 3.9% over the prior month, substantially outperforming the broader S&P 500 composite index which declined 1.3% during the same period. The stock currently maintains a Zacks Rank of #2 (Buy), indicating analyst confidence in near-term outperformance relative to the overall market. This rating reflects recognition that despite the modest EPS surprise, NTR’s underlying operational metrics—particularly pricing strength and year-over-year growth rates across core segments—position the company favorably for continued performance.